Nath Bio Genes India Ltd vs Sampre Nutritions Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Sep 30, 2026

Key Highlights

The Latest Trading Price of Nath Bio-Genes (India) Ltd is ₹ 142.9 as of 30 Sep 15:30 . The P/E Ratio of Nath Bio-Genes (India) Ltd changed from 7.7 on March 2023 to 0 on March 2022 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Sampre Nutritions Ltd changed from 178.9 on March 2023 to 0 on March 2022 . This represents a CAGR of -100.00% over 5 years The Market Cap of Nath Bio-Genes (India) Ltd changed from ₹ 269.29 crore on March 2023 to ₹ 405.45 crore on March 2022 . This represents a CAGR of 8.53% over 5 yearsThe Market Cap of Sampre Nutritions Ltd changed from ₹ 62.7 crore on March 2023 to ₹ 0 crore on March 2022 . This represents a CAGR of -100.00% over 5 years The revenue of Nath Bio-Genes (India) Ltd for the Jun '26 is ₹ 331.5 crore as compare to the Mar '26 revenue of ₹ 55.23 crore. This represent the growth of 500.22% The revenue of Sampre Nutritions Ltd for the Jun '26 is ₹ 14.92 crore as compare to the Mar '26 revenue of ₹ 15.77 crore. This represent the decline of -5.39% The ebitda of Nath Bio-Genes (India) Ltd for the Jun '26 is ₹ 38.25 crore as compare to the Mar '26 ebitda of ₹ 8.11 crore. This represent the growth of 371.64% The ebitda of Sampre Nutritions Ltd for the Jun '26 is ₹ 1.57 crore as compare to the Mar '26 ebitda of ₹ 1.1 crore. This represent the growth of 42.73% The net profit of Nath Bio-Genes (India) Ltd changed from ₹ 33.35 crore to ₹ 32.26 crore over 9 quarters. This represents a CAGR of -1.47% The net profit of Sampre Nutritions Ltd changed from ₹ 0.1 crore to ₹ 0.7 crore over 9 quarters. This represents a CAGR of 137.46% The Dividend Payout of Nath Bio-Genes (India) Ltd changed from 6.83 % on March 2021 to 0 % on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of Sampre Nutritions Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Nath Bio-Genes (India) Ltd

Nath Bio-Genes (India) Limited was originally incorporated in the name and style of 'Shivnath Farms Private Limited' as Private Limited Company which thereafter was converted into Public Limited Company on 13 September, 2000 under the name and style of Shivnath Farms Limited' and further changed from Shivnath Farms Limited to Nath Bio-Genes (India) Limited on March 05, 2001. The Company stands as a distinguished leader in the Indian seed industry, leveraging over two decades of expertise in producing and distributing high-quality seeds to Indian farmers.
The Company's robust research and development initiatives have yielded numerous acclaimed cotton seed varieties, noted for their resilience against viruses and weather fluctuations, as evidenced by their outstanding performance in ICAR trials.

About Sampre Nutritions Ltd

Sampre Nutritions Limited., incorporated in 1991 was promoted by The Gurbani Group, having its works at Medchal, in Andhra Pradesh.
The Company is into the activity of manufacturing of Sugar Candies.
The Company has been manufacturing candy products for its major customer, Cadbury India Ltd since August 1996.
In 2000, it entered into agreement to manufacture 'DAIRY MILK ECLAIRS'. During 1999, the Company commissioned two new projects for manufacture of Jelly in cups under the brand name 'GOLLUM' and 'Mr POPS'. The company was also into the production of HERICOF Cough Lozenges for Ranbaxy Laboratories Ltd, whereby it manufactures CHESTO cough drops for export to its customer 'The Maharaja Organisation Ltd' of Sri Lanka. During 2000, the Company got a major break-through during as it has commenced supplying confectionery products from April 2000 to the various depots of the Indian Airlines across the country The Company launched 6 flavors of Hard Boiled Candy under 'Sampre' Brand in first phase during the year 2018.

FAQs for the comparison of Nath Bio-Genes (India) Ltd and Sampre Nutritions Ltd

Which company has a larger market capitalization, Nath Bio-Genes (India) Ltd or Sampre Nutritions Ltd?

Market cap of Nath Bio-Genes (India) Ltd is 271 Cr while Market cap of Sampre Nutritions Ltd is 58 Cr

What are the key factors driving the stock performance of Nath Bio-Genes (India) Ltd and Sampre Nutritions Ltd?

The stock performance of Nath Bio-Genes (India) Ltd and Sampre Nutritions Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Nath Bio-Genes (India) Ltd and Sampre Nutritions Ltd?

As of September 30, 2026, the Nath Bio-Genes (India) Ltd stock price is INR ₹142.9. On the other hand, Sampre Nutritions Ltd stock price is INR ₹6.13.

How do dividend payouts of Nath Bio-Genes (India) Ltd and Sampre Nutritions Ltd compare?

To compare the dividend payouts of Nath Bio-Genes (India) Ltd and Sampre Nutritions Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.